Table 4 Long-term outcomes of the patients, according to RDW levels

Mean follow-up time (mounth)

66.5 ± 9.96

67.69 ± 8.54

65.43 ± 11

0.004*

MACCE Free Survival

65.33 ± 12.4

67.68 ± 8.54

63.19 ± 14.76

<0.001*

MACCE (1 year)

12 (2.4)

2 (0.8)

10 (3.8)

0.030*

MACCE (3 year)

23 (4.6)

2 (0.8)

21 (8)

<0.001*

MACCE (6 year)

39 (7.8)

8 (3.4)

31 (11.8)

<0.001*

STEMI

8 (1.6)

1 (0.4)

7 (2.7)

0.045*

Total Stroke

9 (1.8)

2 (0.8)

7 (2.7)

0.12

Total TIA

29 (5.8)

5 (2.1)

24 (9.2)

0.001*

Late reintervention

13 (2.6)

4 (1.7)

9 (3.4)

0.22

Stent

12 (2.4)

4 (1.7)

8 (3.1)

0.31

Redo-CABG

1 (0.2)

0

1 (0.4)

0.34

All-cause mortality

29 (5.8)

7 (2.9)

22 (8.4)

0.009*

Cardiovascular mortality

19 (3.8)

4 (1.7)

15 (5.3)

0.018*

Non-Cardiovascular mortality

10 (2)

3 (1.3)

7 (2.7)

0.26